Bergman, Daniel R. https://orcid.org/0000-0002-2166-6616
Fertig, Elana J.
Article History
First Online: 14 April 2025
Competing interests
: E.J.F. has been a paid consultant to Mestag Therapeutics, Viosera Therapeutics/Resistance Bio and Merck, and received funding from Roche/Genetech and AbbVie outside the scope of this work.